| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A new player in IDH1 mutated myeloid neoplasias
|
Heuser, Michael
|
|
|
10 |
1 |
p. e7-e8
|
artikel
|
| 2 |
A world, connected
|
León, Andrés Gómez-De
|
|
|
10 |
1 |
p. e10
|
artikel
|
| 3 |
Barriers in the diagnosis of pulmonary embolism
|
Rezende, Suely Meireles
|
|
|
10 |
1 |
p. e11
|
artikel
|
| 4 |
Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial
|
Herrera, Alex F
|
|
|
10 |
1 |
p. e14-e23
|
artikel
|
| 5 |
Correction to Lancet Haematol 2023; 10: e46–58
|
|
|
|
10 |
1 |
p. e9
|
artikel
|
| 6 |
Current status of phase 3 clinical trials in high-risk myelodysplastic syndromes: pitfalls and recommendations
|
Garcia-Manero, Guillermo
|
|
|
10 |
1 |
p. e71-e78
|
artikel
|
| 7 |
High-risk relapsed or refractory classic Hodgkin lymphoma cure: how to make the impossible possible
|
Gallamini, Andrea
|
|
|
10 |
1 |
p. e2-e3
|
artikel
|
| 8 |
How does zanubrutinib fare in treatment of B-cell malignancies?
|
Shirley, D'Sa
|
|
|
10 |
1 |
p. e5-e6
|
artikel
|
| 9 |
Álvaro Urbano-Ispizua—a more accessible last chance for patients
|
Cavanaugh, Ray
|
|
|
10 |
1 |
p. e12
|
artikel
|
| 10 |
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial
|
Watts, Justin M
|
|
|
10 |
1 |
p. e46-e58
|
artikel
|
| 11 |
Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial
|
Jabbour, Elias
|
|
|
10 |
1 |
p. e24-e34
|
artikel
|
| 12 |
Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT
|
Polverelli, Nicola
|
|
|
10 |
1 |
p. e59-e70
|
artikel
|
| 13 |
Strengthening cancer care in Europe
|
The Lancet Haematology,
|
|
|
10 |
1 |
p. e1
|
artikel
|
| 14 |
Towards chemotherapy-free treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia
|
Boer, Judith M
|
|
|
10 |
1 |
p. e3-e5
|
artikel
|
| 15 |
Towards reparatory measures: blood donation, health systems, and men who have sex with men
|
Peace, Akadinma Eberechukwu
|
|
|
10 |
1 |
p. e13
|
artikel
|
| 16 |
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study
|
Shadman, Mazyar
|
|
|
10 |
1 |
p. e35-e45
|
artikel
|
Tijdschrift beschrijving